The current outbreak of COVID19, caused by severe acute respiratory syndrome
coronavirus 2 (SARSCoV2), is characterised by clinical signs and symptoms such as …

Comment www. thelancet. com/rheumatology Vol 3 January 2021 e7 before the onset of
clinical symptoms; and the presence of human leukocyte anti gen (HLA)-DR alleles that …

With the COVID-19 pandemic, there has been great uncertainty about whether the virus
could exacerbate autoimmune diseases such as rheumatoid arthritis given that infection can …

We read with interest the studies by Renaud Felten and colleagues1 and Laura Boekel and
colleagues2 published in The Lancet Rheumatology, which both contribute essential …

The COVID-19 pandemic has spread across New York City, NY, USA, affecting more than
150 000 of its 8· 5 million inhabitants as of April 26, 2020. 1 Severe illness resulting in …

There is a continuous debate about the risks of increased incidence of COVID-19 in
vulnerable patient groups, which includes patients with rheumatic diseases and especially …

The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
changed life significantly worldwide. Rheumatologists also had to get used to the new …

Vaccination is an important and effective tool to prevent infections in the general population,
as well as in patients with autoimmune and inflammatory rheumatic diseases. It has been …

Severe acute respiratory syndrome coronavirus 2 (SARSCoV2) is the pathogen that causes
COVID19, the cause of a pandemic that is currently threatening millions of lives globally …

As a rheumatology community, we looked on the new decade with excitement and ambition
yet now instead find ourselves amidst the most significant global public healthcare …